期刊文献+

替硝唑结肠定位缓释微丸的制备及释放度考察

Preparation and dissolution study of tinidazole colon specific sustained-release pellets
下载PDF
导出
摘要 目的制备替硝唑结肠定位缓释微丸并考察其体外释放度。方法以肠溶性和渗透性丙烯酸树脂为包衣材料,利用正交设计优化包衣处方,评价其体外释放特性。结果内层包衣液处方为:以质量分数为20%的PEG-6 000为致孔剂,以Eudragit NE 30 D为包衣材料,包衣增量为10%,内层包衣微丸在pH 6.5的磷酸盐缓冲液中具有较好的缓释作用。外层包衣液为Eudragit FS 30 D,包衣增量为10%,在模拟胃肠道各区段最高和最低pH变化的释放度试验中,均在对应小肠区段时开始缓慢释药,分别有质量分数为50%和质量分数为70%的药物进入结肠后释放。结论本制剂优于单独的肠溶或缓释制剂。 Objective To prepare and study on the dissolution of tinidazole colon specific sustained-release pellets.Method Taking acrylic acid resin as coating material and the optimal coating formulation was selected by the orthogonal design.The in vitro release was also evaluated.Results The content of PEG-6000 in the optimal inner coating formulation was 20 %,and Eudragit NE30 D was used for coating,meanwhile,pellets coating weight gain was 10 %.The inner coated pellets show a sustained-release behavior in pH6.5 phosphate buffer.Eudragit FS 30 D was taken as outer coating material,and pellets coating weight gain was 10 %.With the mimic release tests of high pH and low pH profile,the release from the coated pellets was initiated in the small bowel,and about 50% and 70% of the drug was released to colon region,respectively.Conclusion The pellets of this study are much superior to the formulations simply with either entecric polymer or sustained-release polymer.
出处 《中国药剂学杂志(网络版)》 2007年第5期229-233,共5页 Chinese Journal of Pharmaceutics:Online Edition
关键词 药剂学 替硝唑 结肠定位 缓释微丸 正交设计 pharmaceutics tinidazole colon specific sustained-release pellets orthogonal design
  • 相关文献

参考文献7

二级参考文献23

  • 1张举之 主编.口腔内科.第3版[M].北京:人民卫生出版社,1995.314.
  • 2Nagent, Ranpton, Evans, et al. Intestinal Iuminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs[J]. Gut ,2001 ; 48:571-577.
  • 3Markus WR, Klein S, Thomas EB ,et al. A new 5-aminosalicylic acid multi-unit dosage from for the therapy of ulcerative colitis[J].Eur J Pharm, 2001, 51:183-190.
  • 4Evans DF, Pye G, Bramley R, et al,Measurement of gastrointestinal pH profiles in normal ambulant human subjects[J]. Gut,1988,29:1035-41.
  • 5Rodriguez M, Jose L, Vila-Jato, et al. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region[J]. J Control Release ,1998,55:67-77.
  • 6Ashford M, Fell JT, Attwood D, et al. An in vitro investigation into the suitability of pH-dependent polymers for colonic targeting[J]. Int J Pharm, 1993,93:193-199.
  • 7Caroline MS,Donna MT,Budesonide[J],Drugs, 1995,59(5):854-872.
  • 8Peter JW, Lisheth L. Colonic drag delivery[ J ]. Drug Dev Indus Pharm, 1997, 23(9): 893-913.
  • 9Shirodaria S, Smith J, Mckay IJ, et al. Polymorphisms in the IL- 1A gene are correlated with levels of interleukin - 1 alpha protein in gingival Crevicular fluid of teeth with severe periodotal disease[J]. J Dent Res, 2000, 79:1864-1869.
  • 10Cullinan MP, westerman B, Hamlet SM, et al. A longitudinal study of interleukin- 1 gene Polymorphisms and periodontal disease in a general adult population [ J ]. J Clin Periodontol,2001,28:1137-1144.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部